Tristel PLC on Tuesday said its Tristel ULT device has been approved by Health Canada as a high-level disinfectant for use on endocavity ultrasound probes and skin surface transducers.
The.
Tristel PLC on Tuesday celebrated what it expects to be a record first half, after seeing revenue growth thanks to a strong performance across all of its markets.
For the six months ending December.
Infection prevention products developer Tristel flagged a record-breaking first half in an update on Tuesday, with expected revenues of £20.7m for the six months ending 31 December.
The global surface disinfectant market is expected to grow with a CAGR of 7.7% from 2023 to 2028 texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.